Der Klinikarzt 2009; 38(6): 284-290
DOI: 10.1055/s-0029-1233435
Schwerpunkt

© Georg Thieme Verlag Stuttgart · New York

Die Karotisstenose im Fokus klinischer Studien – Chirurgie, Angioplastie oder medikamentöse Therapie?

Carotid occlusive disease focused by clinical studies – Surgery, angioplasty or drug treatment?Marius Hornung1 , Stefan C. Bertog2 , Jennifer Franke1 , Nina Wunderlich1 , Horst Sievert1
  • 1CardioVasculäres Centrum Frankfurt am Main (Chefarzt: Prof. Dr. med. Horst Sievert)
  • 2Veterans Affairs Medical Center, Minneapolis, Minnesota, USA (Chefarzt: Prof. Dr. med. Edward McFalls)
Further Information

Publication History

Publication Date:
26 June 2009 (online)

Der Nutzen der Karotischirurgie, verglichen mit der alleinigen medikamentösen Therapie von Patienten mit symptomatischen und asymptomatischen Karotisstenosen konnte zu Beginn der 90er Jahre durch verschiedene randomisierte Studien (NASCET, ECST, ACAS, ACST) nachgewiesen werden. Die Karotisangioplastie ist eines der innovativsten Felder auf dem Gebiet endovaskulärer Interventionen und wird mittlerweile bereits in vielen Zentren weltweit routinemäßig durchgeführt. Trotz ähnlicher Ergebnisse im Vergleich beider Interventionen (z. B. CAVATAS, SPACE) ist die Angioplastie noch nicht als gleichwertige Alternative zur Chirurgie anerkannt. Jedoch wird durch zunehmende Erfahrungen der Interventionalisten, durch die Entwicklung neuer Stents, Filter und Embolieprotektionen und durch die kürzlich abgeschlossene CREST–Studie sowie noch laufende Studien (TACIT, ICSS, ACT 1) erwartet, endgültig die Äquivalenz oder sogar Überlegenheit der stentgestützten Karotisangioplastie im Vergleich zur Chirurgie aufzeigen zu können.

The benefit of carotid surgery compared to medical treatment in patients who suffer from symptomatic carotid stenosis as well as from asymptomatic ones has been shown in the early 1990s by several randomized trials (NASCET, ECST, ACAS, ACST). Carotid stenting is one of the most dynamic and innovative fields in the area of vascular interventions and is now performed routinely in many centers worldwide. Nevertheless, despite similar trial results comparing both interventions (CAVATAS, SPACE), there is still no general agreement whether stenting should be accepted as an alternative method to surgery or not. But due to the interventionalists' gaining expertise and experience as well as the design of new stents, filters and embolic protection devices with already completed trials (CREST) as well as ongoing trials (TACIT, ICSS, ACT 1) may to prove equivalence or even superiority of carotid artery stenting compared to surgery.

Literatur

  • 1 Donald Lloyed–Jones. et al. . Heart Disease and Stroke Statistics 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  Circulation. 2009;  119
  • 2 Bates ER, Babb JD, Casey Jr. DE. et al. . ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting).  J Am Coll Cardiol. 2007;  49 126-170
  • 3 Timsit SG, Sacco RL, Mohr JP. et al. . Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism.  Stroke. 1992;  23 486-491
  • 4 O'Leary DH, Polak JF, Kronmal RA. et al. . Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.  Stroke. 1992;  23 1752-1760
  • 5 Beneficial effect of carotid endarterectomy in symptomatic patients with high–grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.  N Engl J Med. 1991;  325 445-453
  • 6 Kidwell CS, Alger JR, Di F Salle. et al. . Diffusion MRI in patients with transient ischemic attacks.  Stroke. 1999;  30 1174-1180
  • 7 Ferguson GG, Eliasziw M, Barr HW. et al. . The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients.  Stroke. 1999;  30 1751-1758
  • 8 Sillesen H.. The Natural History of Patients with Carotid Stenosis.  Pathophysiol Haemost Thromb. 2002;  32 378-380
  • 9 Alamowitch S, Eliasziw M, Algra A. et al. . Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal–carotid–artery stenosis.  Lancet. 2001;  357 1154-1160
  • 10 Benavente O, Eliasziw M, Streifler JY. et al. . Prognosis after transient monocular blindness associated with carotid–artery stenosis.  N Engl J Med. 2001;  345 1084-1090
  • 11 Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).  Lancet. 1998;  351 1379-1387
  • 12 Cunningham EJ, Bond R, Mehta Z. et al. . Long–term durability of carotid endarterectomy for symptomatic stenosis and risk factors for late postoperative stroke.  Stroke. 2002;  33 2658-2663
  • 13 Rothwell PM, Eliasziw M, Gutnikov SA. et al. . Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery.  Lancet. 2004;  363 915-924
  • 14 Executive Committee for the Asymptomatic Carotid Atherosclerotic Study. . Endarterectomy for asymptomatic carotid artery stenosis.  JAMA. 1995;  273 1421-1428
  • 15 Baker WH, Howard VJ, Howard G, Toole JF.. Effect of contralateral occlusion on long–term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS Investigators.  Stroke. 2000;  31 2330-2334
  • 16 Halliday A, Mansfield A, Marro J. et al. . Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.  Lancet. 2004;  363 1491-1502
  • 17 Chambers BR, Donnan GA.. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005
  • 18 Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomized trial.  Lancet. 2001;  357 1729-1723
  • 19 Yadav JS, Wholey MH, Kuntz RE. et al. . Protected carotid–artery stenting versus endarterectomy in high–risk patients (the SAPPHIRE study).  N Engl J Med. 2004;  351 1493-1501
  • 20 Mas JL, Trinquvart L, Leys D. et al. . Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA–3S) trial: results up to 4 years from randomised, multicentre trial.  Lancet Neurol. 2008;  10 885-892
  • 21 SPACE Collaborative Group. . 30 day results from the SPACE trial of stent–protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non–inferiority trial.  Lancet. 2006;  368 1239-1247
  • 22 Hobson 2nd RW, Howard VJ, Roubin GS. et al. . Carotid artery stenting is associated with increased complications in octogenarians: 30–day stroke and death rates in the CREST lead–in phase.  J Vasc Surg. 2004;  40 1106-1111
  • 23 ICSS. .International Carotid Stenting Study. Protocol Verion 3.2; 22nd November 2007
  • 24 Katzen BT.. The Transatlantic Asymptomatic Carotid Intervention Trial.  Endovascular Today. 2005;  9 49-50

Korrespondenz

Prof. Dr. med. Horst Sievert

CardioVasculäres Centrum Sankt Katharinen

Seckbacher Landstraße 65

60389 Frankfurt am Main

Fax: 069/4603-1343

Email: horstsievertmd@aol.com

    >